About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Hospital de Madrid
›
top-articles
Hospital de Madrid
24
(top 1%)
papers
1.1K
(top 1%)
citations
13
(top 1%)
h
-index
21
(top 1%)
g
-index
25
all documents
1.2K
doc citations
489
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
Annals of Oncology
2018
388
2
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
2021
329
3
Pain in Parkinson disease: A review of the literature
Parkinsonism and Related Disorders
2013
122
4
Pregnancy after uterine fibroid embolization: follow-up of 100 patients embolized using tris-acryl gelatin microspheres
Fertility and Sterility
2008
55
5
Evaluation of intervertebral disc herniation and hypermobile intersegmental instability in symptomatic adult patients undergoing recumbent and upright MRI of the cervical or lumbosacral spines
European Journal of Radiology
2007
50
6
P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
Journal of Thoracic Oncology
2016
38
7
Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).
Journal of Clinical Oncology
2016
31
8
OA14.04 Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
Journal of Thoracic Oncology
2019
29
9
Targeting
FGFR1
-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398.
Journal of Clinical Oncology
2014
27
10
A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology
2015
27
11
Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain
Acta Paediatrica, International Journal of Paediatrics
2010
24
12
Deep Tissue Hypersensitivity to Pressure Pain in Individuals with Unilateral Acute Inversion Ankle Sprain
Pain Medicine
2012
17
13
Abstract CT195: Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
Cancer Research
2019
13
14
Low-dose spinal anesthesia for urgent laparotomy in severe myasthenia gravis
Saudi Journal of Anaesthesia
2013
8
15
Eficacia y seguridad de un tratamiento oral a base de mucopolisacáridos, colágeno tipo i y vitamina C en pacientes con tendinopatías
Apunts Medicine De L'Esport
2014
6
16
From Node to Pathway Blockade: Lessons Learned From Targeting Mammalian Target of Rapamycin
Journal of Clinical Oncology
2012
5
17
Lurbinectedin (PM01183) with doxorubicin (DOX), an active treatment as second-line therapy in small cell lung cancer (SCLC).
Journal of Clinical Oncology
2015
3
18
Influencing cancer treatment
Lancet Oncology, The
2015
2
19
Tumor infiltrating lymphocytes before and after dual HER2 blockade in HER2-amplified early breast cancer: A TRYPHAENA substudy.
Journal of Clinical Oncology
2016
2
20
A phase 1b study of the anti-cancer stem cell agent demcizumab (DEM), pemetrexed (PEM) & carboplatin (CARBO) in pts with 1
st
line non-squamous NSCLC.
Journal of Clinical Oncology
2015
1
21
P3.07-012 Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases
Journal of Thoracic Oncology
2017
0
22
Implantes con grabado ácido y pasivado químico: estudio preliminar sobre carga precoz
Avances En Periodoncia E ImplantologÍa Oral
2001
0
23
High level of suppressor-of-fused (SuFu) expression and tumor cells dissemination in human glioblastoma.
Journal of Clinical Oncology
2014
0
24
GBM cell microvesicles carrying gDNA oncogenic sequences cross the BBB and reach the peripheral blood.
Journal of Clinical Oncology
2014
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.